Program at a glance (Hybrid)

Download

*The program is tentative and subject to change.

Time
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
10:20-10:40
Coffee Break
12:40-13:40
Lunch
15:40-16:00
Coffee Break
16:00-18:00
2022 Annual Meeting of the KSNO
09:00-18:30
Exhibition
08:00-08:10
Break
11:30-11:50
Break
12:50-13:10
Coffee Break
15:40-16:00
Coffee Break
09:00-18:30
Exhibition
08:00-08:25
Break
11:30-11:50
Break
12:50-13:10
Coffee Break
15:40-16:00
Coffee Break
18:30-18:40
Break
18:40-21:00
Gala DinnerHarmony Ballroom, InterContinental Seoul Coex
09:00-13:00
Exhibition
08:00-08:15
Break
09:45-10:00
Coffee Break
13:00-13:10
Break
07:00-08:00
Opening Symposium 1Raising the Understanding of Stemness, Plasticity and Hierarchy in CNS Malignancies
07:00-08:00
Opening Symposium 10Tumor Microenvironment and Interactions
07:00-08:00
Opening Symposium 11Overview and Novel Techniques in Radiotherapy for Meningiomas
07:00-08:00
Opening Symposium 12Genomics and Therapeutic Implication of Pediatric CNS Tumors
07:00-08:00
Opening Symposium 2Awake Craniotomy for Brain Tumors
07:00-08:00
Opening Symposium 3Neuro-oncologic Imaging: Metabolic and Biomarker Imaging
07:00-08:00
Opening Symposium 4New Horizon of Pediatric Glial Tumor
07:00-08:00
Opening Symposium 5Over the Barrier for Meningioma
07:00-08:00
Opening Symposium 6Integrative Management of Brain Metastasis
07:00-08:00
Opening Symposium 7Biomedical Engineering Approach for Brain Tumors
07:00-08:00
Opening Symposium 8CNS Germ Cell Tumor 
07:00-08:00
Opening Symposium 9BBB modulation for the Treatment of Brain Tumors
07:55-08:00
Education Day Opening
08:00-09:00
Molecular Pathology 2022Molecular Pathology 2022
08:10-08:25
Opening Ceremony
08:15-08:45
Keynote Lecture ASNO
08:25-08:55
Keynote Lecture EANO
08:25-08:55
Keynote Lecture SNO
08:45-09:45
Symposium 17Cutting Edge Approaches for Brain Tumor Treatment
08:45-09:45
Symposium 18How to See and Treat in Brain Tumors (PDD & PDT)
08:45-09:45
Symposium 19Telomere and Glioma
08:45-09:45
Symposium 20Systemic Treatment of Brain Metastasis and Leptomeningeal Metastasis
08:55-10:15
Plenary Session 2Brain Circuit and Glioma
08:55-10:15
Plenary Session 3
08:55-10:15
Plenary Session 3New Insights in Neuro-Oncology
09:00-10:20
Plenary Session 1Cell of Origin
10:00-11:30
Keynote & Scientific Session 20Metastatic Brain Tumors I
10:00-11:30
Keynote & Scientific Session 17Low Grade Gliomas
10:00-11:30
Keynote & Scientific Session 18Meningiomas, Schwannomas I
10:00-11:30
Keynote & Scientific Session 19Gliomas: Biomarker, Neuro-imaging
10:15-11:30
WFNOS 2022 Top 10 Session 1
10:15-11:30
WFNOS 2022 Top 10 Session 2
10:40-11:40
Education Session 1Recent Progress of Artificial Intelligence in Neuro-oncology Imaging
10:40-11:40
Education Session 2Immune Microenvironment in Gliomas
10:40-11:40
Education Session 3Conducting Neuro-oncology Clinical Trials
11:30-13:00
Keynote & Scientific Session 21Multi-disciplinary Approach
11:30-13:00
Scientific Session 22Meningiomas, Schwannomas II
11:30-13:00
Scientific Session 23Sellar Region Tumors
11:30-13:00
Scientific Session 24Metastatic Brain Tumors II
11:40-12:40
Education Session 4Pediatric Type Diffuse Glioma
11:40-12:40
Education Session 5Spatio-Temporal Evolution of Gliomas
11:40-12:40
Education Session 6Clinical Trials for Adult Brain Tumors
11:50-12:50
Luncheon Seminar 1Circumscribed Glioma, Glioneuronal Tumor and Ependymoma
11:50-12:50
Luncheon Seminar 2Updates on RANO Criteria for Response Evaluation
11:50-12:50
Luncheon Seminar 3Re-evaluating SRS for High Grade Glioma
11:50-12:50
Luncheon Seminar 4Next Generation of Precision Medicine for Brain Tumors
11:50-12:50
Luncheon Seminar 5Multidisciplinary Treatment of Primary CNS Lymphoma
11:50-12:50
Luncheon Seminar 6Updates and On-going Clinical Trials for Pediatric Brain Tumors
13:10-13:40
Closing Ceremony
13:10-14:40
Keynote & Scientific Session 3Gliomas: Immunotherapy and Uncommon Tumors
13:10-14:40
Keynote & Scientific Session 4Gliomas: Cancer Stem Cell
13:10-14:40
Keynote & Scientific Session 2Gliomas: Surgery and Clinical Research
13:10-14:40
Keynote & Scientific Session 1Gliomas: Molecular Pathology
13:10-14:40
Keynote & Scientific Session 10Gliomas: Translational Research
13:10-14:40
Keynote & Scientific Session 11QOL, Epidemiology
13:10-14:40
Keynote & Scientific Session 12Pediatric Brain Tumors I
13:10-14:40
Keynote & Scientific Session 9Gliomas: Immuno-Oncology
13:40-14:40
Education Session 7Role of Surgery in Malignant Brain Tumors
13:40-14:40
Education Session 8Cell of Origin in Glioblastoma
13:40-14:40
Education Session 9Systemic Treatment for High Grade Glioma
14:40-15:40
Education Session 10Functional Anatomy and Brain Mapping for Brain Tumor Surgery
14:40-15:40
Education Session 11Relationship of Brain Circuit and Glioma
14:40-15:40
Education Session 12Management of Chemotherapy Side Effects
14:40-15:40
Symposium 9ASNO Meeting for Neuropathology and Neurooncology
14:40-15:40
Symposium 3Role of Epigenetic Alteration in Cancer
14:40-15:40
Symposium 4Relapsed Medulloblastoma
14:40-15:40
Symposium 2Beyond the Limits of Endoscopic Skull Base Surgery
14:40-15:40
Symposium 1Featured Clinical Trials for Newly Diagnosed Glioblastoma
14:40-15:40
Symposium 10Liquid Biopsy Applications for Brain Tumor
14:40-15:40
Symposium 11Cancer Predisposition Syndrome in Pediatric Brain Tumor
14:40-15:40
Symposium 12Evolution in SRS for Brain Metastases
16:00-17:00
Symposium 13Metabolic Targeting for Brain Tumor
16:00-17:00
Symposium 14Modifying Glioblastoma Microenvironment with Local Therapies
16:00-17:00
Symposium 15Symptom Management in Brain Tumor
16:00-17:00
Symposium 16CNS Tumors Outside the Gene Mutation Box
16:00-17:00
Symposium 5Featured Clinical Trials for Recurrent Glioblastoma
16:00-17:00
Symposium 6Advance in Anti-glioma Strategy
16:00-17:00
Symposium 7Neuro-oncologic Imaging: Microenvironmental Imaging
16:00-17:00
Symposium 8Familial Predisposition of CNS Tumors
16:00-17:00
Education Session 13Technical Innovations in Brain Tumor Surgery
16:00-17:00
Education Session 14Gut-CNS Axis for Brain Tumor
16:00-17:00
Education Session 15Quality of Life and More Among Brain Tumor Patients
16:00-18:00
2022 Annual Meeting of the KSNO
17:00-18:00
Education Session 16Endoscopic Skull Base Surgery
17:00-18:00
Education Session 17Glioma Epigenetics: Glioma and Histone Remodeling
17:00-18:00
Education Session 18Advanced Practice Nursing for Patients with Brain Tumors
17:00-18:30
Keynote & Scientific Session 13Gliomas: Genomics, Metabolism
17:00-18:30
Keynote & Scientific Session 14Gliomas: Clinical Trials
17:00-18:30
Keynote & Scientific Session 15CNS Lymphoma
17:00-18:30
Keynote & Scientific Session 16Pediatric Brain Tumors II
17:00-18:30
Keynote & Scientific Session 5Gliomas: Signaling, Microenvironment
17:00-18:30
Keynote & Scientific Session 6Gliomas: Surgery
17:00-18:30
Keynote & Scientific Session 7Gliomas: Novel therapeutics, Radiotherapy, and Machine Learning
17:00-18:30
Keynote & Scientific Session 8Uncommon CNS Tumors
18:00-19:00
ASNO Reformation Ceremony
18:00-19:00
Sponsored Symposium 1Hyundai Pharm
18:00-19:00
Sponsored Symposium 2MSD Korea
18:30-19:30
Sponsored Symposium 3Tumor Treating Fields: A Force for Change (Novocure GmbH)
18:30-19:30
Sponsored Symposium 4The Art of Preventing Bleeding during Neurosurgery (Baxter International Inc.)
18:30-19:30
Sponsored Symposium 5Dawonmedax Co.,ltd